JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120143

Paclitaxel, Anticancer agent

5

(1 Review)

|

(17 Publications)

MW 853.9 Da, Purity >98%. Anticancer agent. Inhibits depolymerization of microtubules, causing mitotic arrest in cancer cells, and apoptosis.
2 Images
Functional Studies - Paclitaxel, Anticancer agent (AB120143)
  • FuncS

PubMed

Functional Studies - Paclitaxel, Anticancer agent (AB120143)

E2 inhibits Paclitaxel induced androgen-independent prostate cancer cell death.

(A-D) 100 nM of E2 was added to the media of (A and B) LNCaP and (C and D) PC3 cells for 96h, followed by addition of Paclitaxel at the indicated concentrations for 24h. The cells were stained with Hoechst 33258 (5 μg/ml) to visualize nuclei and propidium iodide (PI) (0.2 μg/ml) to detect membrane damage (B and D). Cell death was quantified by scoring the number of PI positive cells relative to the total number cell nuclei in the same visual field (A and C). The values represent the mean ± S.E. of at least three independent experiments. * denotes p<0.05, ** denotes p<0.01, and *** denotes p<0.001.

E2 = 17-β-estradiol

(From Figure 1 of Dong et al).

Dong et al PLoS One. 2013; 8(12): e83519. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Chemical Structure - Paclitaxel, Anticancer agent (AB120143)
  • Chemical Structure

Lab

Chemical Structure - Paclitaxel, Anticancer agent (AB120143)

2D chemical structure image of ab120143, Paclitaxel, Anticancer agent

Key facts

CAS number

33069-62-4

Purity

>98%

Form

Solid

form

Molecular weight

853.9 Da

Molecular formula

C<sub>4</sub><sub>7</sub>H<sub>5</sub><sub>1</sub>NO<sub>1</sub><sub>4</sub>

PubChem

36314

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 25 mM

Biochemical name

Paclitaxel

Biological description

Anticancer agent. Inhibits depolymerization of microtubules, causing mitotic arrest in cancer cells, and apoptosis.

Canonical smiles

CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C

Isomeric smiles

CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C

InChi

InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1

InChiKey

RCINICONZNJXQF-MZXODVADSA-N

IUPAC Name

[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Neoplasia (New York, N.Y.) 59:101092 PubMed39615107

2024

Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents.

Applications

Unspecified application

Species

Unspecified reactive species

Rocco Caggiano,Evgeniia Prokhorova,Lena Duma,Kira Schützenhofer,Raffaella Lauro,Giuliana Catara,Rosa Marina Melillo,Angela Celetti,Rebecca Smith,S John Weroha,Scott H Kaufmann,Ivan Ahel,Luca Palazzo

The EMBO journal 43:5288-5326 PubMed39261663

2024

Systematic mapping of mitochondrial calcium uniporter channel (MCUC)-mediated calcium signaling networks.

Applications

Unspecified application

Species

Unspecified reactive species

Hilda Delgado de la Herran,Denis Vecellio Reane,Yiming Cheng,Máté Katona,Fabian Hosp,Elisa Greotti,Jennifer Wettmarshausen,Maria Patron,Hermine Mohr,Natalia Prudente de Mello,Margarita Chudenkova,Matteo Gorza,Safal Walia,Michael Sheng-Fu Feng,Anja Leimpek,Dirk Mielenz,Natalia S Pellegata,Thomas Langer,György Hajnóczky,Matthias Mann,Marta Murgia,Fabiana Perocchi

Journal of neurochemistry 168:100-114 PubMed38102893

2023

Mechanisms of aquaporin-4 vesicular trafficking in mammalian cells.

Applications

Unspecified application

Species

Unspecified reactive species

Andrea Markou,Philip Kitchen,Ahmed Aldabbagh,Mariaelena Repici,Mootaz M Salman,Roslyn M Bill,Zita Balklava

Experimental and therapeutic medicine 26:474 PubMed37664670

2023

Regulation of the stem‑like properties of estrogen receptor‑positive breast cancer cells through NR2E3/NR2C2 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Shanglun Xie,Yaru Hu,Jiacheng Jin,Lingzhi Fu,Cong Zhang,Qing Yang,Yaxin Niu,Zhiyong Sheng

Scientific reports 13:351 PubMed36611083

2023

Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wojciech Szlasa,Olga Michel,Natalia Sauer,Vitalij Novickij,Damian Lewandowski,Paulina Kasperkiewicz,Mounir Tarek,Jolanta Saczko,Julita Kulbacka

Molecules (Basel, Switzerland) 27: PubMed35566044

2022

Anticancer Efficacy of 6-Gingerol with Paclitaxel against Wild Type of Human Breast Adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kamila Wala,Wojciech Szlasa,Natalia Sauer,Paulina Kasperkiewicz-Wasilewska,Anna Szewczyk,Jolanta Saczko,Nina Rembiałkowska,Julita Kulbacka,Dagmara Baczyńska

Bioengineered 12:8419-8434 PubMed34661511

2021

Identification of a prognostic chemoresistance-related gene signature associated with immune microenvironment in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Mingzhou Liu,Qiaoyan Li,Ningmin Zhao

Cardiovascular toxicology 20:261-280 PubMed31571030

2019

Oleic Acid Protects from Arsenic-Induced Cardiac Hypertrophy via AMPK/FoxO/NFATc3 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jayeeta Samanta,Arunima Mondal,Srimoyee Saha,Santanu Chakraborty,Arunima Sengupta

Nature communications 9:4049 PubMed30282987

2018

Bi-directional cell-pericellular matrix interactions direct stem cell fate.

Applications

Unspecified application

Species

Unspecified reactive species

Silvia A Ferreira,Meghna S Motwani,Peter A Faull,Alexis J Seymour,Tracy T L Yu,Marjan Enayati,Dheraj K Taheem,Christoph Salzlechner,Tabasom Haghighi,Ewa M Kania,Oommen P Oommen,Tarek Ahmed,Sandra Loaiza,Katarzyna Parzych,Francesco Dazzi,Oommen P Varghese,Frederic Festy,Agamemnon E Grigoriadis,Holger W Auner,Ambrosius P Snijders,Laurent Bozec,Eileen Gentleman

Biomaterials 176:13-23 PubMed29852376

2018

Neighboring cells override 3D hydrogel matrix cues to drive human MSC quiescence.

Applications

Unspecified application

Species

Unspecified reactive species

Silvia A Ferreira,Peter A Faull,Alexis J Seymour,Tracy T L Yu,Sandra Loaiza,Holger W Auner,Ambrosius P Snijders,Eileen Gentleman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com